Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II trial update on neoadjuvant FOLFOXIRI chemotherapy for resectable liver metastases from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastasis

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: China Medical University, China | Conditions: Colorectal Neoplasms, Drug Therapy | Phase 2 | Status: UNKNOWN